Academic evaluation and assessment: I regularly act as evaluator for academic promotion applicants of national/international universities [multiple times eg. Hong Kong, Amsterdam, Athens, Israel (all 2012-)]. I was part of international expert panel for Heart & Stroke Foundation Canada endowed Chair renewal committee (2015).
I regularly act as examiner, nationally/internationally (under/postgraduate exams), a eg. Vienna (2013), Pisa (2014), Adelaide (2014), London (2016) I am a regular peer review for research grants from national/international funders, including research councils from various countries. I have been part of external peer review evaluation panels for research funding awards, with site evaluation visits to Mainz (2012) and Leuven (2016).
Other teaching and education initiatives: I led the development of the European Heart Rhythm Association(EHRA) AF patient education website [www.afibmatters.org]. Since 2013, translated into French/German/Spanish/Italian versions.
AF patient counselling/education methodology from my TREAT trial [PMID: 24040156] has been implemented into outpatient clinical services, & adopted by other units. This approach is ‘good practice example’ in NICE NOAC (new anticoagulants) Implementation Consensus (2014). With US collaborators, I helped develop an education/decision support tool, AF Guideline Support Tool (AFGuST), which improves quality-adjusted life expectancy for a primary care AF population [PMID:25205788]. This patient-tailored tool bridges the gap between guidelines & practice, facilitating shared decision making, with good results (PMID:25690491). Ongoing research now focuses on NHS implementation. Locally, I have been supporting GP leads from Clinical Commissioning Groups in disseminating programmes for bridging primary-secondary care AF management (2015-). This integrates of primary-secondary care management pathways, esp. new anticoagulants for AF and venous thromboembolism with CCGs and Trust (2015). I have also been conducting up-skilling programme for local GPs on AF, in close collabotations with Clinical Commissioning Groups (2015-).
Miscellaneous: I have advised/written for UpToDate [popular resource for teaching/education, updated 3x/year], Oxford Textbook of Medicine (AF and Hypertension chapters, 5th ed. 2015, includes MCQs) and ESC Textbook of Cardiovascular Medicine (Part of ESC core curriculum for European cardiologists – section lead, for new edition 2016) I have advised and written for BMJ Point of Care (2010-), and the Royal College of Physicians Map of Medicine (2010-).
- I have been conferred four honorary doctorate degrees - doctor medicinae honoris causa from Aalborg University, Denmark (http://bit.ly/2fGyIfC); University of Medicine & Pharmacy “Carol Davila”, Bucharest, Romania (http://bit.ly/2f2yY7p); Belgrade University, Serbia; and i'Universite de Tours, France
- Appointed as Chairman of the Writing Group of the new international American College of Chest Physicians (ACCP Guidelines on Antithrombotic therapy for AF (10th edition, 2016-), the first non-US chairman of these guidelines. Previously served as writing committee member for the 8th and 9th ACCP guideline editions. For the 9th ACCP guideline (2012), I was appointed as ‘content expert’ (ie. ’deputy editor’) for the AF guideline chapter.
- European Society of Cardiology and European Heart Rhythm Association (EHRA): Chairman (2011-2015; and still remain on Executive Steering Committee, as ‘Past Chairman’ 2016-) of the European Society of Cardiology (ESC) EuroObservational Research Programme on Atrial Fibrillation (EORP-AF), defining the epidemiology and management of AF in Europe. I have also managed and developed international registry collaborations with ESC/non-ESC countries (Asia-Pacific HRS, Japan, China, Serbia, Iran) as part of the INTER-AF collaboration (see PMID: 27806965). I am a member of the INTER-AF steering committee, which is an American College of Cardiology-led collaboration of academics developing AF registry dataset harmonisation and inter-regional comparisons.
Since 2012, I have chaired 6 ESC/European Heart Rhythm Association (EHRA) consensus guidelines eg. Arrhythmias in AF with Heart failure (2015); AF with Acute coronary syndrome/Stenting (2014); valvular AF, hypertension (2016-2017).
Member, ESC Clinical Practice Guideline Committee (2014-2016); my work included implementation recommendations, self-testing modules & assessment of quality/audit standards. Peer reviewer of 8 ESC guidelines since 2012. Review Coordinator, 2015 ESC ventricular arrhythmia guidelines.
2015-2017, EHRA Board member/Chair, Scientific Documents Committee, coordinated new guideline development/reviews & facilitated implementation/education. In 2017 was appointed to the EHRA Governing Board as ‘Research Pillar’ Chairman, responsible for scientific initiatives/innovation and scientific documents. In 2014-2015, Chaired group developing EHRA AF patient education website (afibmatters.org) & translation into multilanguages
National Institute for Health and Care Excellence (NICE): External expert and co-author for the NICE AF Quality Standards (2015): helped defined standards/benchmarking & co-author (2015). I was co-author, NICE Patient Pathways to accompany AF guideline & NICE NOAC Implementation Consensus (2014). I am an Expert Adviser for NICE Centre for Clinical Practice (including NICE Medicines & Prescribing Centre; 2016-). Clinical adviser to the UK NICE guidelines on atrial fibrillation (2006) and the subsequent NICE implementation/commissioning committee on anticoagulation for AF (2007). I was the clinical expert to NICE, also representing the British Cardiovascular Society, on its evaluation of dabigatran (2011) and apixaban (2013) for stroke prevention in AF (2011). I was on the Guideline Development Group for the latest UK NICE guidelines on atrial fibrillation (2014), and part of the NICE Guideline surveillence review for AF (2016-2017).
Appointed to SIGN (Scottish Intercollegiate Guidelines Network (2016-) producing healthcare guidelines/service standards for NHS Scotland.
National Institute for Health Research (NIHR): I was independent chairman of trial steering committee for NIHR Research for Patient Benefit-funded randomised trial: Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT) (PMID:26314489); I am a regular contributor of commentaries to NIHR Dissemination Centre and a regular peer reviewer of NIHR grants and study reports for NIHR Journals Library. I am principal investigator of the NIHR EME-funded IMPRESS-AF trial, and co-applicant for ongoing NIHR-funded Research for Patient Benefit randomised trial (CBT-AF) which investigates cognitive behavioural therapy & education/counselling to improve outcomes in AF (2015-). Currently member of NIHR College of Senior Investigators (2017-).
Grant review panels: Welcome Trust; Research Councils of Hong Kong/Sweden/Netherlands/Singapore; Ontario Research Fund; Canadian Institutes of Health Research. Chairman of grants evaluation panel, Research Council for Norway (2014). Chairman, ERISTA grants programme award committee (2015-2016): annual chairing international expert committee, coordinating reviews & assessment/evaluation of research proposals. I am part of a multinational expert research evaluation committee for Leuven University (2016). Regular evaluation for academic promotion applicants from national/international universities [eg. Hong Kong, Amsterdam, Athens, Israel; Johns Hopkins Baltimore (USA), Singapore, etc (2012-)]. Part of international expert panel for Heart & Stroke Foundation Canada endowed Chair renewal committee (2015)
I currently serve as data safety management board (DSMB member for a Canadian Institutes for Health Research (CIHR) funded trial – BRUISE/BRUISE2 (2009-ongoing).
External expert reviewer, 2016 Taiwan Society of Cardiology and Taiwan Heart Rhythm Society joint guidelines on AF management. Expert external reviewer for 2017 Asia-Pacific Heart Rhythm Society AF guidelines (2017).
I was part of a BMJ Writing group (2013) for NHS Shared Decision Making in the development of a patient decision aid for stroke prevention for AF or atrial flutter [http://sdm.rightcare.nhs.uk/pda/stroke-prevention-for-atrial-fibrillation]
I am member of Council, Royal College of Physicians of Edinburgh (2015-) and have acted as West Midlands Regional Adviser for the RCPE (2013-).
In 2009, I was appointed Visiting Professor in Aston University, Birmingham. In 2011, I was conferred the title of Adjunct Professor in Aalborg University, Denmark – for research and teaching. I also hold Visiting Chairs in Belgrade, Beijing, Leeds, Taiwan, China, etc – primarily for research leadership.
As mentioned above, I have Chaired various task forces for the European Society of Cardiology, European Heart Rhythm Association (EHRA) and European Heart Failure Association, and was on various national/international guideline writing committees. I recently served on the scientific documents committee (2009-2011) and scientific initiatives committed (2011-2013) of EHRA. From 2013, I have been appointed to the EHRA Board, as Chairman of the Scientific Documents Committee (2013-). I am a writing committee member of an ESC Working Group on Thrombosis task force on Anticoagulants (2011-ongoing), producing a series of expert reviews and consensus documents on the use of anticoagulants in heart disease. I was Chair of a EHRA Task Force that developed the EHRA patient information website for AF (2013, see www.afibmatters.org).
I am currently on the congress programme committee for the ESC congress (the world’s largest cardiology conress, 2016-), as well as Cardiostim and EHRA-Europace meetings (2011-), both being the major scientific meetings of EHRA. I was Chair of the organisation and programme committee for the Royal College of Physicians of Edinburgh Consensus Conference on Atrial Fibrillation, March 2012.
I was invited as an ‘international technical expert’ in a Duke University Evidence-based Practice Center report "Stroke Prevention in Atrial Fibrillation", in partnership with the Agency for Healthcare Research and Quality (AHRQ) (USA, 2011-12). I was a contributor to the US-led Antiplatelet- Academic Research Consortium (ARC) initiative (2015).
I was cardiovascular lead for the Birmingham and Black Country Comprehensive Local Research Network (BBC CLRN) from 2010-2011. I was appointed UK Chief Investigator for 2 major non-industry academic multinational projects – the National Institutes for Health NINDS [cooperative agreements U01 NS43975 and U01 NS39143], USA, for WARCEF (Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction) study (2010-), and more recently, the Netherlands Heart Foundation funded RACE-3 trial (Routine vs Aggressive Upstream rhythm control for prevention of early atrial fibrillation in heart failure; 2011-).
I am on the expert medical advisory committee (with other international experts on AF) for 2 major international patient organisations involved in atrial fibrillation – the AF Association (http://www.atrialfibrillation.org.uk) and Stopafib.org (http://stopafib.org) (both 2009-).
Editorial leadership: I am Editor in Chief (Clinical Studies) [2010-] of ‘Thrombosis & Haemostasis’ (2016 Impact factor 5.627). Also regular Guest Editor for ‘Circulation’ (2009-). I am an Associate Editor for ‘Europace’ (the main journal for the European Heart Rhythm Association; 2009-). I am on the editorial boards of many of the main journals in the field, including the following (all with Impact Factor >4.0): Journal of the American College of Cardiology, European Heart Journal, Circulation, Atherosclerosis Thrombosis & Vascular Biology, Heart, American Journal of Cardiology, American Heart Journal, Chest, American Journal of Medicine, etc.